Drugs that contain Insulin Lispro Recombinant
1. Humalog patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5514646 | LILLY | Insulin analogs modified at position 29 of the B chain |
May, 2013
(10 years ago) | |
| US5474978 | LILLY | Insulin analog formulations |
Jun, 2014
(9 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NR(NR) | Oct 12, 2015 |
Market Authorisation Date: 15 November, 2019
Treatment: Humalog is an insulin analog that is indicated in the treatment of patients with diabetes mellitus for the control of hyperglycemia
Dosage: INJECTABLE;INJECTION
HUMALOG family patents
2. Humalog Kwikpen patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5514646 | LILLY | Insulin analogs modified at position 29 of the B chain |
May, 2013
(10 years ago) | |
| US5474978 | LILLY | Insulin analog formulations |
Jun, 2014
(9 years ago) | |
| US7291132 | LILLY | Medication dispensing apparatus with triple screw threads for mechanical advantage |
Aug, 2024
(3 months from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NR(NR) | Oct 12, 2015 |
Market Authorisation Date: 15 November, 2019
Treatment: Use for the treatment of hyperglycemia; Treatment of diabetes mellitus
Dosage: INJECTABLE;INJECTION
HUMALOG KWIKPEN family patents
3. Humalog Kwikpen patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6551992 | ELI LILLY AND CO | Stable insulin formulations |
Jun, 2018
(5 years ago) | |
| US6034054 | ELI LILLY AND CO | Stable insulin formulations |
Jun, 2018
(5 years ago) | |
| US7291132 | ELI LILLY AND CO | Medication dispensing apparatus with triple screw threads for mechanical advantage |
Aug, 2024
(3 months from now) | |
Market Authorisation Date: 26 May, 2015
Treatment: Treatment of irritable bowel syndrome with diarrhea (ibs-d) in adults and symptoms thereof.
Dosage: SOLUTION;SUBCUTANEOUS
HUMALOG KWIKPEN family patents
4. Humalog Pen patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5514646 | LILLY | Insulin analogs modified at position 29 of the B chain |
May, 2013
(10 years ago) | |
| US5474978 | LILLY | Insulin analog formulations |
Jun, 2014
(9 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NR(NR) | Oct 12, 2015 |
Market Authorisation Date: 15 November, 2019
Treatment: Humalog is an insulin analog that is indicated in the treatment of patients with diabetes mellitus for the control of hyperglycemia
Dosage: INJECTABLE;INJECTION
HUMALOG PEN family patents